| 3001 | Electrocardiogram morphology (amplitude at temporal datapoints) adjusted, T384 | ECGA000384 | 5.37 |
| 3002 | Volume of left cortical nucleus | GCST90474964 | 5.37 |
| 3003 | IDP dMRI ProbtrackX ICVF ar r | GCST90004376 | 5.37 |
| 3004 | FOLR1 levels | GCST90469259 | 5.36 |
| 3005 | IDP dMRI TBSS ISOVF Posterior thalamic radiation L | GCST90004506 | 5.36 |
| 3006 | Melanocytic naevi of trunk | FING00000800 | 5.36 |
| 3007 | SLITRK1 levels | GCST90470669 | 5.35 |
| 3008 | Systolic blood pressure | GCST90018752 | 5.35 |
| 3009 | Electrocardiogram morphology (amplitude at temporal datapoints) unadjusted, T24 | ECGU000024 | 5.35 |
| 3010 | DTI TBSS MD External capsule R | GCST90384604 | 5.35 |
| 3011 | MATN2/SCARA5 ratio | GCST90315388 | 5.35 |
| 3012 | T1 brain MRIs Unsupervised Deep learning derived Imaging Phenotypes (dimension 65) | GCST90320628 | 5.34 |
| 3013 | Hepatic cancer | GCST90018638 | 5.33 |
| 3014 | Polyunsaturated fatty acids to total fatty acids percentage | GCST90499299 | 5.32 |
| 3015 | T1 FreeSurfer BA rh V2 exvivo thickness | GCST90385571 | 5.32 |
| 3016 | CALCA levels | GCST90468528 | 5.32 |
| 3017 | Types of physical activity in last 4 weeks - Walking for pleasure (not as a means of transport) | Physical activity | UKBB00000875 | 5.32 |
| 3018 | IDP dMRI ProbtrackX L2 ifo r | GCST90004286 | 5.32 |
| 3019 | Breast conditions, congenital or relating to hormones (PheCode 612) | GCST90476162 | 5.31 |
| 3020 | Migraine with aura | FING00000819 | 5.31 |
| 3021 | aparc-DKTatlas rh area precuneus | GCST90003288 | 5.31 |
| 3022 | Electrocardiogram morphology (amplitude at temporal datapoints) unadjusted, T268 | ECGU000268 | 5.30 |
| 3023 | Electrocardiogram morphology (amplitude at temporal datapoints) unadjusted, T331 | ECGU000331 | 5.30 |
| 3024 | Electrocardiogram morphology (amplitude at temporal datapoints) adjusted, T453 | ECGA000453 | 5.30 |
| 3025 | Citrulline levels | GCST90200403 | 5.30 |
| 3026 | Illnesses of father - Diabetes | Family history | UKBB00000341 | 5.30 |
| 3027 | Sedentary behavior at work | GCST90104345 | 5.29 |
| 3028 | Electrocardiogram morphology (amplitude at temporal datapoints) unadjusted, T476 | ECGU000476 | 5.29 |
| 3029 | IDI2 levels | GCST90469505 | 5.29 |
| 3030 | Electrocardiogram morphology (amplitude at temporal datapoints) adjusted, T375 | ECGA000375 | 5.28 |
| 3031 | PROS1 levels | GCST90470337 | 5.27 |
| 3032 | COL6A3/HSPG2 ratio | GCST90314175 | 5.27 |
| 3033 | Electrocardiogram morphology (amplitude at temporal datapoints) unadjusted, T193 | ECGU000193 | 5.27 |
| 3034 | wg lh intensity-contrast posteriorcingulate | GCST90003814 | 5.27 |
| 3035 | Electrocardiogram morphology (amplitude at temporal datapoints) unadjusted, T470 | ECGU000470 | 5.26 |
| 3036 | Coronary revascularization (ANGIO or CABG) | FING00000360 | 5.26 |
| 3037 | Hereditary ataxia | FING00000610 | 5.26 |
| 3038 | Urinary albumin excretion | GCST006586 | 5.25 |
| 3039 | IL18BP/THBD ratio | GCST90315156 | 5.25 |
| 3040 | Electrocardiogram morphology (amplitude at temporal datapoints) unadjusted, T29 | ECGU000029 | 5.25 |
| 3041 | PPCDC/RWDD1 ratio | GCST90315704 | 5.24 |
| 3042 | DTI TBSS L1 Fornix | GCST90384433 | 5.24 |
| 3043 | F12 levels | GCST90469166 | 5.24 |
| 3044 | aseg lh volume Inf-Lat-Vent | GCST90002617 | 5.24 |
| 3045 | Left ventricular end diastolic mass end diastolic volume ratio | GCST90268131 | 5.24 |
| 3046 | Electrocardiogram morphology (amplitude at temporal datapoints) adjusted, T362 | ECGA000362 | 5.23 |
| 3047 | Electrocardiogram morphology (amplitude at temporal datapoints) adjusted, T322 | ECGA000322 | 5.23 |
| 3048 | Heart rate variability (standard deviation of normal-to-normal intervals) | GCST90281265 | 5.23 |
| 3049 | T1 FreeSurfer a2009s rh S calcarine area | GCST90384933 | 5.23 |
| 3050 | Electrocardiogram morphology (amplitude at temporal datapoints) adjusted, T371 | ECGA000371 | 5.23 |
| 3051 | IDP dMRI TBSS L1 Superior fronto-occipital fasciculus R | GCST90004117 | 5.22 |
| 3052 | EXTL1 levels | GCST90469161 | 5.21 |
| 3053 | Phosphatidylcholine-O_33:3_[M+H]1+/Phosphatidylcholine-P_33:2_[M+H]1+/Phosphatidylethanolamine-O_36:3_[M+H]1+ levels | GCST90060261 | 5.20 |
| 3054 | VNN1 levels | GCST90471043 | 5.19 |
| 3055 | Triglycerides in large LDL | GCST90498076 | 5.18 |
| 3056 | Electrocardiogram morphology (amplitude at temporal datapoints) unadjusted, T488 | ECGU000488 | 5.18 |
| 3057 | DTI autoptx L1 atr r tract | GCST90385142 | 5.18 |
| 3058 | Diacylglycerol_38:5_[M+H-H2O]1+ levels | GCST90060200 | 5.18 |
| 3059 | T1 brain MRIs Unsupervised Deep learning derived Imaging Phenotypes (dimension 4) | GCST90320567 | 5.17 |
| 3060 | Triglycerides | GCST000758 | 5.17 |
| 3061 | Cryptic phenotype that captures alpha-1-antitrypsin deficiency severity | GCST90101825 | 5.17 |
| 3062 | IDP dMRI TBSS MD Cingulum cingulate gyrus R | GCST90004061 | 5.17 |
| 3063 | Falling risk | GCST90012857 | 5.17 |
| 3064 | Butternut squash liking | GCST90094718 | 5.17 |
| 3065 | Average diameter for VLDL particles | GCST90093002 | 5.16 |
| 3066 | CTBS levels | GCST90468900 | 5.16 |
| 3067 | T1 brain MRIs Unsupervised Deep learning derived Imaging Phenotypes (dimension 68) | GCST90320631 | 5.15 |
| 3068 | SIRPA levels | GCST90470639 | 5.15 |
| 3069 | Omega-6 fatty acids to total fatty acids percentage | GCST90502541 | 5.15 |
| 3070 | Coxarthrosis [arthrosis of hip] | Arthrosis | UKBB00000154 | 5.14 |
| 3071 | Hemoglobin concentration | GCST90002311 | 5.14 |
| 3072 | Non-cancer illness code, self-reported - gout | Medical conditions | UKBB00000512 | 5.14 |
| 3073 | Electrocardiogram morphology (amplitude at temporal datapoints) adjusted, T301 | ECGA000301 | 5.14 |
| 3074 | Phospholipids to Total Lipids in Medium HDL percentage | GCST90498653 | 5.14 |
| 3075 | Average diameter for LDL particles | GCST90498458 | 5.14 |
| 3076 | DTI autoptx MD ifo r tract | GCST90385233 | 5.13 |
| 3077 | Cardiomyopathy (excluding other) | FING00000251 | 5.13 |
| 3078 | IDP dMRI ProbtrackX L2 ilf l | GCST90004287 | 5.13 |
| 3079 | ICD10 N80: Endometriosis | GCST90454213 | 5.13 |
| 3080 | Posterior diffusion tensor imaging along the perivascular space index | GCST90455545 | 5.13 |
| 3081 | SLC39A5 levels | GCST90470661 | 5.13 |
| 3082 | Heel bone mineral density | GCST006288 | 5.12 |
| 3083 | Lysoalkylphosphatidylcholine (O-24:1) levels | GCST90024813 | 5.12 |
| 3084 | total creatine kinase (mean, inv-norm transformed) | GCST90476413 | 5.12 |
| 3085 | ANGPTL3/TFPI ratio | GCST90313270 | 5.12 |
| 3086 | BAG6/WASF1 ratio | GCST90313452 | 5.11 |
| 3087 | Electrocardiogram morphology (amplitude at temporal datapoints) unadjusted, T320 | ECGU000320 | 5.11 |
| 3088 | Triglycerides in VLDL (UKB data field 23408) | GCST90269505 | 5.11 |
| 3089 | Parental longevity (both parents in top 10%) | GCST006698 | 5.10 |
| 3090 | Electrocardiogram morphology (amplitude at temporal datapoints) adjusted, T290 | ECGA000290 | 5.10 |
| 3091 | Treatment or medication use - ezetimibe (UKB data field 20003_1141192736) | GCST90042541 | 5.10 |
| 3092 | Electrocardiogram morphology (amplitude at temporal datapoints) adjusted, T359 | ECGA000359 | 5.10 |
| 3093 | Longitudinal peak diastolic strain rate | GCST90019013 | 5.10 |
| 3094 | Osteoporosis, osteopenia and pathological fracture | musculoskeletal | UKBB00000600 | 5.10 |
| 3095 | Pulse pressure | GCST90472783 | 5.10 |
| 3096 | Triglycerides in very small VLDL | GCST90500885 | 5.10 |
| 3097 | Electrocardiogram morphology (amplitude at temporal datapoints) adjusted, T383 | ECGA000383 | 5.10 |
| 3098 | LRRC37A2 levels | GCST90469802 | 5.09 |
| 3099 | Croissant liking | GCST90094748 | 5.09 |
| 3100 | Mean arterial pressure | GCST90018743 | 5.09 |
| 3101 | BTD levels | GCST90468477 | 5.09 |
| 3102 | IDP dMRI ProbtrackX ICVF unc r | GCST90004401 | 5.08 |
| 3103 | HAVCR2/TREM2 ratio | GCST90315031 | 5.08 |
| 3104 | Retinal venular tortuosity | GCST90270399 | 5.08 |
| 3105 | AXL/MCAM ratio | GCST90313421 | 5.07 |
| 3106 | CPXM1/SPARC ratio | GCST90314222 | 5.07 |
| 3107 | Electrocardiogram morphology (amplitude at temporal datapoints) adjusted, T279 | ECGA000279 | 5.07 |
| 3108 | Sphingomyelins levels | GCST90499972 | 5.07 |
| 3109 | IDP T1 FAST ROIs R cerebellum V | GCST90002565 | 5.06 |
| 3110 | rfMRI connectivity (ICA100 edge 1066) | GCST90005919 | 5.05 |
| 3111 | wg lh intensity-contrast cuneus | GCST90003796 | 5.05 |
| 3112 | DTI TBSS L2 Superior longitudinal fasciculus L | GCST90384517 | 5.05 |
| 3113 | YBX1 levels | GCST90090799 | 5.05 |
| 3114 | DTI TBSS MD Uncinate fasciculus R | GCST90384616 | 5.05 |
| 3115 | Total cholesterol levels | GCST90018754 | 5.05 |
| 3116 | Ischemic heart disease (PheCode 411) | GCST90475929 | 5.05 |
| 3117 | Electrocardiogram morphology (amplitude at temporal datapoints) unadjusted, T31 | ECGU000031 | 5.05 |
| 3118 | IDP T1 SIENAX white unnormalised volume | GCST90002433 | 5.05 |
| 3119 | Qualifications - None of the above | Education | UKBB00000729 | 5.04 |
| 3120 | Left-hemisphere limbic network to right-hemisphere limbic network white-matter structural connectivity | GCST90302733 | 5.04 |
| 3121 | Polycystic ovarian syndrome, broad definition | FING00001183 | 5.04 |
| 3122 | A body shape index | GCST90020024 | 5.03 |
| 3123 | Osteoporosis, osteopenia and pathological fracture (PheCode 743) | GCST90476258 | 5.03 |
| 3124 | CHL1 levels | GCST90468745 | 5.03 |
| 3125 | Electrocardiogram morphology (amplitude at temporal datapoints) adjusted, T385 | ECGA000385 | 5.03 |
| 3126 | aparc-DKTatlas rh area fusiform | GCST90003270 | 5.02 |
| 3127 | Electrocardiogram morphology (amplitude at temporal datapoints) adjusted, T367 | ECGA000367 | 5.01 |
| 3128 | Electrocardiogram morphology (amplitude at temporal datapoints) unadjusted, T232 | ECGU000232 | 5.01 |
| 3129 | Free cholesterol to total lipids ratio in medium LDL | GCST90092909 | 5.01 |
| 3130 | Fasting plasma glucose | GCST90297787 | 5.00 |
| 3131 | Malignant neoplasm of bronchus and lung | Malignant neoplasms of respiratory and intrathoracic organs | UKBB00000425 | 5.00 |
| 3132 | aparc-a2009s lh area S-orbital-H-Shaped | GCST90003360 | 5.00 |
| 3133 | SIL1 levels | GCST90470638 | 5.00 |
| 3134 | Free cholesterol levels in chylomicrons and extremely large VLDL | GCST90500965 | 5.00 |
| 3135 | Right ventricular end diastolic volume | GCST90268116 | 4.99 |
| 3136 | aparc-Desikan lh area postcentral | GCST90003094 | 4.99 |
| 3137 | Takes medication for high cholesterol? | GCST90475208 | 4.99 |
| 3138 | Electrocardiogram morphology (amplitude at temporal datapoints) adjusted, T373 | ECGA000373 | 4.99 |
| 3139 | Guilty feelings | Mental health | UKBB00000291 | 4.98 |
| 3140 | IDP dMRI ProbtrackX L1 cgh l | GCST90004252 | 4.98 |
| 3141 | Cholesteryl Esters in Small VLDL | GCST90499786 | 4.98 |
| 3142 | Electrocardiogram morphology (amplitude at temporal datapoints) adjusted, T379 | ECGA000379 | 4.98 |
| 3143 | Open bite | FING00000903 | 4.98 |
| 3144 | Right ventricular end systolic volume | GCST90268118 | 4.97 |
| 3145 | Arthrosis | FING00000111 | 4.97 |
| 3146 | Electrocardiogram morphology (amplitude at temporal datapoints) adjusted, T376 | ECGA000376 | 4.97 |
| 3147 | Electrocardiogram morphology (amplitude at temporal datapoints) unadjusted, T164 | ECGU000164 | 4.97 |
| 3148 | Electrocardiogram morphology (amplitude at temporal datapoints) adjusted, T381 | ECGA000381 | 4.96 |
| 3149 | Raynaud's syndrome | GCST90448187 | 4.96 |
| 3150 | F-wine liking (derived food-liking factor) | GCST90094872 | 4.95 |
| 3151 | ITGBL1 levels | GCST90469648 | 4.95 |
| 3152 | C7 levels | GCST90422332 | 4.95 |
| 3153 | Arabitol/xylitol levels | GCST90200011 | 4.95 |
| 3154 | Stroke | GCST006906 | 4.95 |
| 3155 | Deferral due to hypohemoglobinemia in blood donors | GCST90104113 | 4.95 |
| 3156 | GAL levels | GCST90012062 | 4.94 |
| 3157 | Transport type for commuting to job workplace - Public transport | Employment | UKBB00000828 | 4.94 |
| 3158 | Electrocardiogram morphology (amplitude at temporal datapoints) unadjusted, T293 | ECGU000293 | 4.94 |
| 3159 | Electrocardiogram morphology (amplitude at temporal datapoints) adjusted, T346 | ECGA000346 | 4.94 |
| 3160 | DTI TBSS FA External capsule R | GCST90384412 | 4.94 |
| 3161 | Other disorders of intestine | digestive | UKBB00000608 | 4.93 |
| 3162 | Diastolic blood pressure, automated reading, adjusted by medication | Cardiovascular measurement | UKBB00000175 | 4.93 |
| 3163 | Iliac isthmus breadth | GCST90448907 | 4.93 |
| 3164 | IDP dMRI ProbtrackX L1 atr l | GCST90004248 | 4.93 |
| 3165 | Medication use (antiglaucoma preparations and miotics) | GCST90018782 | 4.93 |
| 3166 | Secondary diabetes mellitus (PheCode 249) | GCST90475655 | 4.93 |
| 3167 | SLAMF8 levels | GCST90470652 | 4.92 |
| 3168 | CD69/CHMP1A ratio | GCST90313868 | 4.92 |
| 3169 | CSPG4 levels | GCST90468890 | 4.92 |
| 3170 | AMY2A levels | GCST90468298 | 4.92 |
| 3171 | aparc-Desikan rh area supramarginal | GCST90003137 | 4.91 |
| 3172 | Heart failure with reduced EF [Systolic or combined heart failure] (PheCode 428.3) | GCST90475983 | 4.91 |
| 3173 | Coronary atherosclerosis (PheCode 411.4) | GCST90475936 | 4.91 |
| 3174 | Urticaria | FING00001408 | 4.91 |
| 3175 | Electrocardiogram morphology (amplitude at temporal datapoints) unadjusted, T240 | ECGU000240 | 4.91 |
| 3176 | MYOC/NOTCH3 ratio | GCST90315507 | 4.91 |
| 3177 | Electrocardiogram morphology (amplitude at temporal datapoints) unadjusted, T479 | ECGU000479 | 4.91 |
| 3178 | CTSH levels | GCST90468913 | 4.90 |
| 3179 | Cancer (standard GWA) | GCST90267270 | 4.90 |
| 3180 | Electrocardiogram morphology (amplitude at temporal datapoints) unadjusted, T234 | ECGU000234 | 4.89 |
| 3181 | Hip circumference | GCST90278633 | 4.89 |
| 3182 | Kyphosis (MTAG) | GCST90570047 | 4.89 |
| 3183 | wg lh intensity-contrast isthmuscingulate | GCST90003801 | 4.87 |
| 3184 | Electrocardiogram morphology (amplitude at temporal datapoints) adjusted, T364 | ECGA000364 | 4.87 |
| 3185 | Cholesteryl Esters in Large VLDL | GCST90498146 | 4.87 |
| 3186 | DTI autoptx FA slf r tract | GCST90385134 | 4.87 |
| 3187 | TTR levels | GCST90470985 | 4.87 |
| 3188 | CPA1/CTRB1 ratio | GCST90314203 | 4.87 |
| 3189 | Intra-ocular pressure, corneal-compensated (right) | Intraocular pressure | UKBB00000375 | 4.87 |
| 3190 | Diseases of arteries, arterioles and capillaries (FINNGEN) | FING00000423 | 4.87 |
| 3191 | Insomnia complaints | GCST006488 | 4.86 |
| 3192 | CD84/GP1BA ratio | GCST90313913 | 4.86 |
| 3193 | wg rh intensity-contrast middletemporal | GCST90003841 | 4.86 |
| 3194 | Docosahexaenoic acid levels (UKB data field 23450) | GCST90269547 | 4.86 |
| 3195 | wg lh intensity-contrast inferiortemporal | GCST90003800 | 4.86 |
| 3196 | IDP dMRI ProbtrackX L3 slf l | GCST90004321 | 4.86 |
| 3197 | Electrocardiogram morphology (amplitude at temporal datapoints) unadjusted, T486 | ECGU000486 | 4.86 |
| 3198 | Left ventricular end diastole anterolateral wall thickness | GCST90278517 | 4.85 |
| 3199 | Osteitis deformans and osteopathies associated with other disorders classified elsewhere (PheCode 731) | GCST90476246 | 4.85 |
| 3200 | IDP dMRI ProbtrackX L1 slf l | GCST90004267 | 4.84 |
| 3201 | IDP dMRI ProbtrackX FA atr l | GCST90003927 | 4.84 |
| 3202 | T1 FreeSurfer DK lh lateraloccipital area | GCST90385598 | 4.84 |
| 3203 | Waist circumference adjusted for body mass index | GCST90020029 | 4.84 |
| 3204 | aparc-DKTatlas lh thickness postcentral | GCST90003560 | 4.84 |
| 3205 | wg lh intensity-contrast parahippocampal | GCST90003807 | 4.83 |
| 3206 | Free cholesterol to total lipids ratio in very small VLDL | GCST90093033 | 4.83 |
| 3207 | Time spent outdoors in winter | Sun exposure | UKBB00000819 | 4.83 |
| 3208 | T1 FreeSurfer aseg Right-Caudate | GCST90384162 | 4.82 |
| 3209 | T1 brain MRIs Unsupervised Deep learning derived Imaging Phenotypes (dimension 125) | GCST90320688 | 4.82 |
| 3210 | ADAM23 levels | GCST90240922 | 4.82 |
| 3211 | ADGRE2/CD58 ratio | GCST90313175 | 4.82 |
| 3212 | LDL (weighted GWA) | GCST90267273 | 4.82 |
| 3213 | PMVK/RHOC ratio | GCST90315697 | 4.82 |
| 3214 | Electrocardiogram morphology (amplitude at temporal datapoints) adjusted, T331 | ECGA000331 | 4.82 |
| 3215 | Electrocardiogram morphology (amplitude at temporal datapoints) adjusted, T338 | ECGA000338 | 4.81 |
| 3216 | CNTN4 levels | GCST90240786 | 4.80 |
| 3217 | JAM2/THBD ratio | GCST90315239 | 4.80 |
| 3218 | Sphingomyelin_32:1_[M+H]1+ levels | GCST90060225 | 4.80 |
| 3219 | Disorders of lipid metabolism (PheCode 272) | GCST90475715 | 4.80 |
| 3220 | Triglycerides in small VLDL (UKB data field 23515) | GCST90269612 | 4.79 |
| 3221 | Diastolic blood pressure, combined automated + manual reading, adjusted by medication | Cardiovascular measurement | UKBB00000179 | 4.79 |
| 3222 | Belittlement by partner or ex-partner as an adult | Traumatic events | UKBB00000091 | 4.79 |
| 3223 | IDP dMRI ProbtrackX L1 atr r | GCST90004249 | 4.79 |
| 3224 | aparc-pial rh area supramarginal | GCST90003204 | 4.79 |
| 3225 | CPA1/PLA2G1B ratio | GCST90314205 | 4.79 |
| 3226 | Androstenediol (3beta,17beta) disulfate (2) levels | GCST90199851 | 4.79 |
| 3227 | Benign neoplasm of colon (PheCode 208) | GCST90475617 | 4.78 |
| 3228 | Myo-inositol levels | GCST90243527 | 4.78 |
| 3229 | ANGPTL7 levels | GCST90468306 | 4.76 |
| 3230 | Electrocardiogram morphology (amplitude at temporal datapoints) adjusted, T17 | ECGA000017 | 4.76 |
| 3231 | Prescriptions - doxazosin | alpha1-antagonist,alpha blocker | UKBB00000679 | 4.76 |
| 3232 | Omega-6 fatty acids to total fatty acids percentage | GCST90499203 | 4.75 |
| 3233 | aparc-a2009s lh area G-postcentral | GCST90003324 | 4.75 |
| 3234 | Polyp of the female genital tract | FING00001190 | 4.75 |
| 3235 | Biological Sibling: Alzheimer's / Other Dementia | GCST90476375 | 4.74 |
| 3236 | Omega-3 fatty acids to Omega-6 fatty acids ratio | GCST90502068 | 4.74 |
| 3237 | Omega-3 fatty acids to Omega-6 fatty acids ratio | GCST90502397 | 4.74 |
| 3238 | IDP dMRI TBSS ICVF Posterior limb of internal capsule L | GCST90004346 | 4.74 |
| 3239 | Globe artichoke liking | GCST90094771 | 4.74 |
| 3240 | GGT5 levels | GCST90469337 | 4.74 |
| 3241 | Intelligence | GCST90179114 | 4.74 |
| 3242 | Hypercholesterolemia | endocrine/metabolic | UKBB00000332 | 4.74 |
| 3243 | Electrocardiogram morphology (amplitude at temporal datapoints) unadjusted, T19 | ECGU000019 | 4.74 |
| 3244 | IDP dMRI TBSS FA Anterior corona radiata L | GCST90003900 | 4.73 |
| 3245 | Phospholipids to total lipids in medium VLDL percentage (UKB data field 23594) | GCST90269691 | 4.73 |
| 3246 | Chronic airway obstruction | respiratory | UKBB00000135 | 4.73 |
| 3247 | Electrocardiogram morphology (amplitude at temporal datapoints) unadjusted, T414 | ECGU000414 | 4.73 |
| 3248 | aparc-Desikan lh area TotalSurface | GCST90003073 | 4.73 |
| 3249 | Volume of left anterior amygdaloid area | GCST90474871 | 4.73 |
| 3250 | Electrocardiogram morphology (amplitude at temporal datapoints) unadjusted, T10 | ECGU000010 | 4.73 |
| 3251 | Pulse pressure | GCST90018750 | 4.73 |
| 3252 | Volume of left basal nucleus | GCST90474877 | 4.73 |
| 3253 | Phosphatidylcholine acyl-alkyl C36:4 levels | GCST90240072 | 4.73 |
| 3254 | Free cholesterol in small HDL | GCST90499411 | 4.73 |
| 3255 | CCDC80/CHRDL1 ratio | GCST90313670 | 4.72 |
| 3256 | Other degenerative diseases of the nervous system | FING00000994 | 4.72 |
| 3257 | Electrocardiogram morphology (amplitude at temporal datapoints) adjusted, T360 | ECGA000360 | 4.72 |
| 3258 | IDP dMRI TBSS OD Tapetum R | GCST90004448 | 4.71 |
| 3259 | Triacylglycerol_56:4_[M+NH4]1+ levels | GCST90060556 | 4.71 |
| 3260 | wg rh intensity-contrast frontalpole | GCST90003858 | 4.71 |
| 3261 | Lysoalkylphosphatidylcholine (O-24:2) levels | GCST90025438 | 4.71 |
| 3262 | IDP dMRI ProbtrackX L1 ilf r | GCST90004261 | 4.70 |
| 3263 | IDP T1 FAST ROIs V cerebellum VIIb | GCST90002576 | 4.70 |
| 3264 | Total lipid levels in chylomicrons and extremely large VLDL | GCST90093046 | 4.69 |
| 3265 | ART3/RGMB ratio | GCST90313363 | 4.69 |
| 3266 | IDP dMRI TBSS L1 Genu of corpus callosum | GCST90004077 | 4.69 |
| 3267 | DTI TBSS L3 Posterior limb of internal capsule R | GCST90384542 | 4.68 |
| 3268 | Volume of left whole amygdala | GCST90474988 | 4.68 |
| 3269 | Free cholesterol in medium LDL | GCST90498767 | 4.68 |
| 3270 | Cholesterol to total lipids ratio in large LDL | GCST90092857 | 4.68 |
| 3271 | CD99/MMP3 ratio | GCST90313928 | 4.68 |
| 3272 | Fracture of forearm | FING00000554 | 4.68 |
| 3273 | Electrocardiogram morphology (amplitude at temporal datapoints) adjusted, T363 | ECGA000363 | 4.68 |
| 3274 | Platelet count | GCST90018749 | 4.68 |
| 3275 | rfMRI connectivity (ICA100 edge 1090) | GCST90005943 | 4.68 |
| 3276 | SFTPD levels | GCST90470614 | 4.68 |
| 3277 | Premature beats (PheCode 427.6) | GCST90475977 | 4.67 |
| 3278 | Hypertension | circulatory system | UKBB00000334 | 4.67 |
| 3279 | DTI TBSS L2 Uncinate fasciculus L | GCST90384521 | 4.67 |
| 3280 | potassium (minimum, inv-norm transformed) | GCST90476310 | 4.67 |
| 3281 | IDP T1 FAST ROIs L cerebellum V | GCST90002564 | 4.66 |
| 3282 | Hyperlipidemia (PheCode 272.1) | GCST90475718 | 4.66 |
| 3283 | aseg global volume TotalGray | GCST90002594 | 4.65 |
| 3284 | Electrocardiogram morphology (amplitude at temporal datapoints) adjusted, T193 | ECGA000193 | 4.65 |
| 3285 | Right-hemisphere somatomotor network to putamen white-matter structural connectivity | GCST90302796 | 4.65 |
| 3286 | Diacylglycerol_44:7_[M+H-H2O]1+ levels | GCST90060240 | 4.65 |
| 3287 | Linoleic acid to total fatty acids percentage | GCST90502023 | 4.65 |
| 3288 | Electrocardiogram morphology (amplitude at temporal datapoints) unadjusted, T330 | ECGU000330 | 4.65 |
| 3289 | Abdominal hernia | digestive | UKBB00000002 | 4.64 |
| 3290 | Free Cholesterol to Total Lipids in Very Large HDL percentage | GCST90500397 | 4.64 |
| 3291 | ACHE levels | GCST90468199 | 4.64 |
| 3292 | Volume of right anterior amygdaloid area | GCST90475003 | 4.64 |
| 3293 | 1-stearoyl-gpc (18:0) levels | GCST90199732 | 4.64 |
| 3294 | Migraine headaches | GCST90475546 | 4.64 |
| 3295 | Congenital iodine-deficiency syndrome/hypothyroidism | FING00000328 | 4.64 |
| 3296 | NAAA levels | GCST90469991 | 4.64 |
| 3297 | Sporadic miscarriage | GCST011888 | 4.63 |
| 3298 | aparc-a2009s lh volume S-postcentral | GCST90002991 | 4.63 |
| 3299 | CXCL3 levels | GCST90468931 | 4.62 |
| 3300 | APCS levels | GCST90468328 | 4.62 |
| 3301 | DTI TBSS L1 Splenium of corpus callosum | GCST90384432 | 4.61 |
| 3302 | Electrocardiogram morphology (amplitude at temporal datapoints) unadjusted, T111 | ECGU000111 | 4.61 |
| 3303 | Spontaneous coronary artery dissection | GCST90245878 | 4.61 |
| 3304 | Provencibacterium massiliense abundance in stool | GCST90032527 | 4.61 |
| 3305 | Principal component-derived dietary pattern 8 | GCST90133013 | 4.61 |
| 3306 | IDP dMRI TBSS ICVF Retrolenticular part of internal capsule L | GCST90004348 | 4.61 |
| 3307 | HSBP1 levels | GCST90469481 | 4.60 |
| 3308 | Electrocardiogram morphology (amplitude at temporal datapoints) unadjusted, T282 | ECGU000282 | 4.60 |
| 3309 | Illnesses of siblings - Heart disease | Family history | UKBB00000351 | 4.60 |
| 3310 | Weight change compared with 1 year ago | General health | UKBB00000911 | 4.60 |
| 3311 | Electrocardiogram morphology (amplitude at temporal datapoints) adjusted, T341 | ECGA000341 | 4.60 |
| 3312 | Comorbidity of gastric and duodenal ulcers | GCST90270929 | 4.59 |
| 3313 | Number of correct matches in round | Pairs matching | UKBB00000532 | 4.59 |
| 3314 | Functional digestive disorders | digestive | UKBB00000274 | 4.59 |
| 3315 | F-whole food liking (derived food-liking factor) | GCST90094868 | 4.58 |
| 3316 | ICA1/YTHDF3 ratio | GCST90315113 | 4.58 |
| 3317 | Triacylglycerol_48:3_[M+NH4]1+ levels | GCST90060418 | 4.57 |
| 3318 | WASL levels | GCST90471070 | 4.57 |
| 3319 | IDP dMRI TBSS MO Superior corona radiata L | GCST90003977 | 4.57 |
| 3320 | Triglycerides in very small VLDL (UKB data field 23522) | GCST90269619 | 4.57 |
| 3321 | ICD10 O12: Gestational oedema and proteinuria without hypertension | GCST90454231 | 4.57 |
| 3322 | Free cholesterol in IDL | GCST90497564 | 4.57 |
| 3323 | total cholesterol (minimum, inv-norm transformed) | GCST90476427 | 4.57 |
| 3324 | Electrocardiogram morphology (amplitude at temporal datapoints) adjusted, T6 | ECGA000006 | 4.56 |
| 3325 | Free cholesterol in large LDL | GCST90497987 | 4.56 |
| 3326 | Hearing difficulty/problems with background noise | Hearing | UKBB00000312 | 4.56 |
| 3327 | Omega-6 fatty acids to total fatty acids percentage | GCST90502540 | 4.55 |
| 3328 | wg rh intensity-contrast supramarginal | GCST90003857 | 4.55 |
| 3329 | Omega-3 fatty acids to total fatty acids percentage | GCST90502087 | 4.55 |
| 3330 | Omega-6 fatty acids to total fatty acids percentage | GCST90502129 | 4.55 |
| 3331 | LCN2/PGLYRP1 ratio | GCST90315306 | 4.55 |
| 3332 | Porridge liking | GCST90094815 | 4.55 |
| 3333 | Metabolic disorders | FING00000816 | 4.55 |
| 3334 | Electrocardiogram morphology (amplitude at temporal datapoints) adjusted, T280 | ECGA000280 | 4.54 |
| 3335 | Capers liking | GCST90094724 | 4.54 |
| 3336 | EPCAM/GPA33 ratio | GCST90314674 | 4.54 |
| 3337 | PTPN1/TDRKH ratio | GCST90315745 | 4.53 |
| 3338 | T1 brain MRIs Unsupervised Deep learning derived Imaging Phenotypes (dimension 126) | GCST90320689 | 4.53 |
| 3339 | ASGR1 levels | GCST90468375 | 4.52 |
| 3340 | Left-hemisphere default mode network to accumbens white-matter structural connectivity | GCST90302773 | 4.52 |
| 3341 | CDCP1 levels | GCST90468667 | 4.52 |
| 3342 | Triacylglycerol_54:3_[M+NH4]1+ levels | GCST90060541 | 4.52 |
| 3343 | Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage | GCST90501091 | 4.52 |
| 3344 | DTI TBSS L2 Posterior corona radiata L | GCST90384503 | 4.51 |
| 3345 | Vascular/heart problems diagnosed by doctor - Heart attack | Medical conditions | UKBB00000897 | 4.51 |
| 3346 | ITIH3/VCAM1 ratio | GCST90315236 | 4.51 |
| 3347 | IDP dMRI TBSS L3 Posterior corona radiata R | GCST90004197 | 4.51 |
| 3348 | Triglyceride to HDL cholesterol ratio | GCST90295951 | 4.51 |
| 3349 | ADGRE5 levels | GCST90425484 | 4.51 |
| 3350 | Electrocardiogram morphology (amplitude at temporal datapoints) adjusted, T70 | ECGA000070 | 4.50 |
| 3351 | Monounsaturated fatty acids to total fatty acids percentage | GCST90502051 | 4.50 |
| 3352 | PON2/PON3 ratio | GCST90315703 | 4.50 |
| 3353 | IDP dMRI TBSS L3 Posterior corona radiata L | GCST90004198 | 4.50 |
| 3354 | PDCD1/TNFRSF9 ratio | GCST90315611 | 4.50 |
| 3355 | Barrett's esophagus (PheCode 530.13) | GCST90476048 | 4.50 |
| 3356 | Total fatty acid levels | GCST90500053 | 4.50 |
| 3357 | Free cholesterol to total lipids in very large VLDL percentage (UKB data field 23587) | GCST90269684 | 4.50 |
| 3358 | MAP2K6/MGMT ratio | GCST90315373 | 4.49 |
| 3359 | aparc-DKTatlas rh area supramarginal | GCST90003294 | 4.49 |
| 3360 | Electrocardiogram morphology (amplitude at temporal datapoints) adjusted, T259 | ECGA000259 | 4.49 |
| 3361 | CGREF1 levels | GCST90468735 | 4.49 |
| 3362 | Hippocampal right GC-ML-DG volume (head) | GCST90267968 | 4.49 |
| 3363 | APOB/APOA1 ratio | GCST90497158 | 4.48 |
| 3364 | Electrocardiogram morphology (amplitude at temporal datapoints) adjusted, T329 | ECGA000329 | 4.48 |
| 3365 | Electrocardiogram morphology (amplitude at temporal datapoints) adjusted, T380 | ECGA000380 | 4.48 |
| 3366 | SERPINF1 levels | GCST90470598 | 4.48 |
| 3367 | IDP dMRI ProbtrackX L3 atr r | GCST90004303 | 4.48 |
| 3368 | APOE levels | GCST90468338 | 4.48 |
| 3369 | 1-(1-enyl-palmitoyl)-2-linoleoyl-GPC (p-16:0/18:2) levels | GCST90200060 | 4.47 |
| 3370 | QC T1 inverse SNR | GCST90006348 | 4.47 |
| 3371 | Self-reported risk-taking behaviour | GCST006810 | 4.47 |
| 3372 | Treatment speciality of consultant (recoded) - Urology | Summary Administration | UKBB00000838 | 4.47 |
| 3373 | LTA/LTBR ratio | GCST90315336 | 4.47 |
| 3374 | Type 2 diabetes with neurological manifestations (PheCode 250.24) | GCST90475676 | 4.47 |
| 3375 | Non-HDL cholesterol levels | GCST90239669 | 4.46 |
| 3376 | Electrocardiogram morphology (amplitude at temporal datapoints) unadjusted, T209 | ECGU000209 | 4.46 |
| 3377 | F7 levels | GCST90469171 | 4.46 |
| 3378 | ESAM/LAMA4 ratio | GCST90314713 | 4.46 |
| 3379 | Triglycerides in small VLDL | GCST90499917 | 4.45 |
| 3380 | T1 brain MRIs Unsupervised Deep learning derived Imaging Phenotypes (dimension 117) | GCST90320680 | 4.45 |
| 3381 | C1QTNF1 levels | GCST90468488 | 4.45 |
| 3382 | T2 brain MRIs Unsupervised Deep learning derived Imaging Phenotypes (dimension 52) | GCST90320871 | 4.44 |
| 3383 | Electrocardiogram morphology (amplitude at temporal datapoints) adjusted, T19 | ECGA000019 | 4.44 |
| 3384 | Triglycerides in LDL | GCST90498472 | 4.44 |
| 3385 | Malignant neoplasm of breast, ER-positive, excluding all cancers (controls excluding all cancers) | FING00000754 | 4.44 |
| 3386 | Myopia | FING00000853 | 4.44 |
| 3387 | Essential hypertension | circulatory system | UKBB00000209 | 4.43 |
| 3388 | Diastolic blood pressure, automated reading, adjusted by medication | Cardiovascular measurement | UKBB00000174 | 4.43 |
| 3389 | IDP T1 FAST ROIs R front operc cortex | GCST90002532 | 4.43 |
| 3390 | FLT3/FLT3LG ratio | GCST90314859 | 4.42 |
| 3391 | Neoplasm of uncertain behavior (PheCode 199) | GCST90475606 | 4.42 |
| 3392 | Electrocardiogram morphology (amplitude at temporal datapoints) unadjusted, T156 | ECGU000156 | 4.42 |
| 3393 | Birth weight known - Yes - pounds and ounces | Early life factors | UKBB00000097 | 4.42 |
| 3394 | PGLS levels | GCST90618925 | 4.42 |
| 3395 | Aneurysm of iliac artery (PheCode 442.2) | GCST90475995 | 4.42 |
| 3396 | Ventricular arrhythmia | GCST90018720 | 4.42 |
| 3397 | HippSubfield rh volume CA4-body | GCST90002705 | 4.41 |
| 3398 | Any mental disorder | FING00000100 | 4.41 |
| 3399 | Hallux rigidus | FING00000600 | 4.41 |
| 3400 | Electrocardiogram morphology (amplitude at temporal datapoints) adjusted, T293 | ECGA000293 | 4.41 |
| 3401 | Principal component-derived dietary pattern 10 | GCST90133015 | 4.41 |
| 3402 | CD5/IL16 ratio | GCST90313861 | 4.41 |
| 3403 | CTSZ/NAAA ratio | GCST90314320 | 4.41 |
| 3404 | End-diastolic bi-ventricular shape (principal component 5) | GCST90448484 | 4.41 |
| 3405 | IDP dMRI ProbtrackX ICVF ptr l | GCST90004394 | 4.41 |
| 3406 | Calculus of lower urinary tract | FING00000237 | 4.40 |
| 3407 | Cholesteryl ester levels in chylomicrons and extremely large VLDL | GCST90093042 | 4.40 |
| 3408 | BCL2L11/RAB6A ratio | GCST90313484 | 4.40 |
| 3409 | Diastolic blood pressure, combined automated + manual reading, adjusted by medication | Cardiovascular measurement | UKBB00000178 | 4.39 |
| 3410 | X-24337 levels | GCST90200629 | 4.39 |
| 3411 | IDP dMRI TBSS ICVF Cingulum cingulate gyrus R | GCST90004361 | 4.38 |
| 3412 | Electrocardiogram morphology (amplitude at temporal datapoints) unadjusted, T290 | ECGU000290 | 4.38 |
| 3413 | Phosphatidylinositol (20:0_20:4) levels | GCST90025083 | 4.38 |
| 3414 | CTSO levels | GCST90468915 | 4.38 |
| 3415 | Electrocardiogram morphology (amplitude at temporal datapoints) unadjusted, T233 | ECGU000233 | 4.38 |
| 3416 | Sphingomyelin_34:0_[M+H]1+ levels | GCST90060241 | 4.37 |
| 3417 | Retinal detachment with retinal break | FING00001259 | 4.37 |
| 3418 | T1 FreeSurfer aseg rhCerebralWhiteMatterVol | GCST90384186 | 4.37 |
| 3419 | Retinal thickness (functional principal component 4) | GCST90455724 | 4.37 |
| 3420 | AXL levels | GCST90468406 | 4.37 |
| 3421 | Electrocardiogram morphology (amplitude at temporal datapoints) unadjusted, T370 | ECGU000370 | 4.37 |
| 3422 | Left-hemisphere control network to right-hemisphere somatomotor network white-matter structural connectivity | GCST90302746 | 4.37 |
| 3423 | Lymphoid neoplasms (drug group 1 phenocluster) | GCST90624740 | 4.36 |
| 3424 | Non-cancer illness code, self-reported - heart attack/myocardial infarction | Medical conditions | UKBB00000514 | 4.36 |
| 3425 | Number of days/week of vigorous physical activity 10+ minutes | Physical activity | UKBB00000534 | 4.36 |
| 3426 | Vitamin and mineral supplements - None of the above | Medication | UKBB00000901 | 4.36 |
| 3427 | IDP dMRI ProbtrackX L1 unc l | GCST90004271 | 4.36 |
| 3428 | Treatment speciality of consultant (recoded) - Ophthalmology | Summary Administration | UKBB00000835 | 4.35 |
| 3429 | IDP dMRI TBSS ICVF Superior longitudinal fasciculus R | GCST90004367 | 4.35 |
| 3430 | How are people in household related to participant - Husband, wife or partner | Household | UKBB00000330 | 4.35 |
| 3431 | IDP dMRI TBSS ICVF Posterior limb of internal capsule R | GCST90004345 | 4.35 |
| 3432 | IL7R levels | GCST90469605 | 4.35 |
| 3433 | Nephritis and nephropathy in diseases classified elsewhere (PheCode 580.31) | GCST90476116 | 4.34 |
| 3434 | Electrocardiogram morphology (amplitude at temporal datapoints) unadjusted, T21 | ECGU000021 | 4.34 |
| 3435 | Methods of admission to hospital (recoded) - Elective admission: Booked | Summary Administration | UKBB00000461 | 4.34 |
| 3436 | IDP dMRI TBSS L3 Anterior corona radiata R | GCST90004193 | 4.33 |
| 3437 | Phosphatidylethanolamine_40:6_[M-H]1- levels | GCST90060365 | 4.32 |
| 3438 | Electrocardiogram morphology (amplitude at temporal datapoints) adjusted, T175 | ECGA000175 | 4.32 |
| 3439 | Cholesterol to total lipids in small HDL percentage (UKB data field 23645) | GCST90269742 | 4.32 |
| 3440 | Other and unspecified polyneuropathies, also in other diseases | FING00000948 | 4.32 |
| 3441 | Electrocardiogram morphology (amplitude at temporal datapoints) adjusted, T370 | ECGA000370 | 4.32 |
| 3442 | DTI TBSS MD Fornix cres+Stria terminalis R | GCST90384610 | 4.32 |
| 3443 | T1 CAT volume R RightPutamen | GCST90384101 | 4.31 |
| 3444 | HippSubfield rh volume Whole-hippocampal-head | GCST90002710 | 4.31 |
| 3445 | Knee osteoarthritis | GCST007090 | 4.31 |
| 3446 | EFEMP1 levels | GCST90469078 | 4.31 |
| 3447 | RAB6A levels | GCST90470412 | 4.31 |
| 3448 | IDP dMRI TBSS ICVF Posterior thalamic radiation L | GCST90004356 | 4.31 |
| 3449 | LGALS8/SOD2 ratio | GCST90315320 | 4.31 |
| 3450 | HLA-DRA levels | GCST90469458 | 4.30 |
| 3451 | FUT3 or FUT5 levels | GCST90469280 | 4.30 |
| 3452 | HBB levels | GCST90025969 | 4.30 |
| 3453 | Left-hemisphere control network to left-hemisphere control network white-matter structural connectivity | GCST90302743 | 4.29 |
| 3454 | Right-hemisphere somatomotor network to right-hemisphere control network white-matter structural connectivity | GCST90302792 | 4.29 |
| 3455 | Electrocardiogram morphology (amplitude at temporal datapoints) adjusted, T340 | ECGA000340 | 4.29 |
| 3456 | S100A16 levels | GCST90470516 | 4.29 |
| 3457 | Atrial fibrillation | GCST90624412 | 4.29 |
| 3458 | IDP dMRI TBSS ICVF Posterior corona radiata R | GCST90004353 | 4.28 |
| 3459 | Gastric polyp | GCST90018630 | 4.28 |
| 3460 | Phenylalanine levels | GCST90499223 | 4.27 |
| 3461 | Osteoporosis | musculoskeletal | UKBB00000598 | 4.27 |
| 3462 | Free cholesterol in IDL | GCST90497561 | 4.26 |
| 3463 | Diastolic blood pressure | GCST90310295 | 4.26 |
| 3464 | Plasma iron levels | GCST90100546 | 4.26 |
| 3465 | Waist circumference | GCST90278648 | 4.25 |
| 3466 | NTRK2 levels | GCST90470097 | 4.25 |
| 3467 | white blood cell count (WBC, maximum, inv-norm transformed) | GCST90476451 | 4.25 |
| 3468 | T1 brain MRIs Unsupervised Deep learning derived Imaging Phenotypes (dimension 41) | GCST90320604 | 4.25 |
| 3469 | T2 brain MRIs Unsupervised Deep learning derived Imaging Phenotypes (dimension 84) | GCST90320903 | 4.25 |
| 3470 | Other and/or unspecified nontoxic goitre | FING00000958 | 4.25 |
| 3471 | DTI autoptx L2 ifo r tract | GCST90385179 | 4.25 |
| 3472 | Left ventricular end systole inferoseptal wall thickness | GCST90278508 | 4.24 |
| 3473 | Nephrotic syndrome | GCST90018664 | 4.24 |
| 3474 | IDP dMRI TBSS L3 Inferior cerebellar peduncle L | GCST90004182 | 4.24 |
| 3475 | Alzheimer's disease (MTAG) | GCST90449062 | 4.23 |
| 3476 | Left-hemisphere visual network to pallidum white-matter structural connectivity | GCST90302665 | 4.23 |
| 3477 | Conduction disorders | FING00000324 | 4.23 |
| 3478 | BCAN/CD200 ratio | GCST90313477 | 4.23 |
| 3479 | wg rh intensity-contrast pericalcarine | GCST90003847 | 4.23 |
| 3480 | Other soft tissue disorders, not elsewhere classified | FING00001099 | 4.22 |
| 3481 | Experiencing mood swings | GCST006944 | 4.22 |
| 3482 | IDP dMRI ProbtrackX ICVF cgh l | GCST90004381 | 4.22 |
| 3483 | Electrocardiogram morphology (amplitude at temporal datapoints) adjusted, T273 | ECGA000273 | 4.22 |
| 3484 | Free cholesterol to total lipids in medium LDL percentage (UKB data field 23622) | GCST90269719 | 4.22 |
| 3485 | Electrocardiogram morphology (amplitude at temporal datapoints) adjusted, T262 | ECGA000262 | 4.22 |
| 3486 | Diverticulosis (PheCode 562.1) | GCST90476076 | 4.22 |
| 3487 | Hip index | GCST012229 | 4.21 |
| 3488 | Secondary hypertension | FING00001285 | 4.21 |
| 3489 | Electrocardiogram morphology (amplitude at temporal datapoints) unadjusted, T477 | ECGU000477 | 4.21 |
| 3490 | Electrocardiogram morphology (amplitude at temporal datapoints) adjusted, T342 | ECGA000342 | 4.21 |
| 3491 | Electrocardiogram morphology (amplitude at temporal datapoints) unadjusted, T256 | ECGU000256 | 4.20 |
| 3492 | IDP dMRI TBSS ICVF Posterior corona radiata L | GCST90004354 | 4.20 |
| 3493 | CTF1/ITGB1BP2 ratio | GCST90314305 | 4.20 |
| 3494 | Triglyceride levels | GCST90239663 | 4.20 |
| 3495 | Lactate levels | GCST90092882 | 4.20 |
| 3496 | Follicular cysts of skin and subcutaneous tissue | FING00000547 | 4.19 |
| 3497 | Drinks usually with meals in current drinkers (yes vs no) (UKB data field 1618) | GCST90132926 | 4.19 |
| 3498 | Lifetime number of sexual partners | Sexual factors | UKBB00000406 | 4.19 |
| 3499 | Major dietary changes in the last 5 years - No | Diet | UKBB00000421 | 4.19 |
| 3500 | DTI TBSS L3 External capsule R | GCST90384556 | 4.19 |
| 3501 | CA1/CA3 ratio | GCST90313572 | 4.19 |
| 3502 | FOLR2/THY1 ratio | GCST90314867 | 4.19 |
| 3503 | IDP dMRI TBSS MD Retrolenticular part of internal capsule R | GCST90004047 | 4.18 |
| 3504 | Gonarthrosis | FING00000585 | 4.18 |
| 3505 | Diseases of oesophagus, stomach and duodenum | FING00000428 | 4.18 |
| 3506 | ANXA3/ENO2 ratio | GCST90313281 | 4.18 |
| 3507 | Electrocardiogram morphology (amplitude at temporal datapoints) unadjusted, T301 | ECGU000301 | 4.18 |
| 3508 | Osteoporosis NOS | musculoskeletal | UKBB00000599 | 4.18 |
| 3509 | HippSubfield rh volume CA1-head | GCST90002696 | 4.18 |
| 3510 | Corneal hysteresis (right) | Intraocular pressure | UKBB00000149 | 4.18 |
| 3511 | Saturated fatty acids levels | GCST90502674 | 4.17 |
| 3512 | IDP dMRI TBSS OD Body of corpus callosum | GCST90004405 | 4.17 |
| 3513 | CALCOCO1/MAP3K5 ratio | GCST90313605 | 4.17 |
| 3514 | Polyunsaturated fatty acids to saturated fatty acids ratio | GCST90502580 | 4.16 |
| 3515 | Sensorineural hearing loss | FING00001291 | 4.16 |
| 3516 | Cirrhosis, broad definition used in the article https://doi.org/10.1101/594523 | FING00000304 | 4.16 |
| 3517 | IDP dMRI ProbtrackX ICVF fma | GCST90004385 | 4.16 |
| 3518 | Peripheral artery disease | GCST90018670 | 4.15 |
| 3519 | Phospholipid levels in large LDL | GCST90132648 | 4.15 |
| 3520 | IDP dMRI TBSS MD Uncinate fasciculus L | GCST90004072 | 4.15 |
| 3521 | Coronary heart disease | GCST000998 | 4.15 |
| 3522 | Electrocardiogram morphology (amplitude at temporal datapoints) adjusted, T68 | ECGA000068 | 4.15 |
| 3523 | Pain type(s) experienced in last month - Stomach or abdominal pain | Pain | UKBB00000633 | 4.14 |
| 3524 | EFEMP1/FSTL3 ratio | GCST90314595 | 4.14 |
| 3525 | Sphingomyelin_42:3_[M+H]1+ levels | GCST90060399 | 4.13 |
| 3526 | wg rh intensity-contrast superiorparietal | GCST90003855 | 4.13 |
| 3527 | Mouth/teeth dental problems - Dentures | Mouth | UKBB00000486 | 4.13 |
| 3528 | Polyunsaturated fatty acid levels | GCST90502619 | 4.12 |
| 3529 | PEPD levels | GCST90470209 | 4.12 |
| 3530 | LDL cholesterol | GCST90018741 | 4.12 |
| 3531 | CCL16 levels | GCST90468568 | 4.12 |
| 3532 | MEGF9/OXT ratio | GCST90315419 | 4.12 |
| 3533 | IDP T1 FAST ROIs L cerebellum X | GCST90002587 | 4.11 |
| 3534 | Mean volume of bilateral amygdala | GCST90474899 | 4.11 |
| 3535 | Concentration of VLDL particles | GCST90500250 | 4.11 |
| 3536 | Electrocardiogram morphology (amplitude at temporal datapoints) unadjusted, T496 | ECGU000496 | 4.11 |
| 3537 | BRK1 levels | GCST90468469 | 4.11 |
| 3538 | Androsterone sulfate levels | GCST90200674 | 4.11 |
| 3539 | Ribothymidine levels in chronic kidney disease | GCST90257554 | 4.10 |
| 3540 | Number of non-cancer illnesses (weighted GWA) | GCST90267291 | 4.09 |
| 3541 | Electrocardiogram morphology (amplitude at temporal datapoints) unadjusted, T460 | ECGU000460 | 4.09 |
| 3542 | Hypertrophy of breast (Gynecomastia) (PheCode 612.2) | GCST90476163 | 4.09 |
| 3543 | wg rh intensity-contrast insula | GCST90003861 | 4.09 |
| 3544 | Free cholesterol to total lipids in IDL percentage (UKB data field 23612) | GCST90269709 | 4.08 |
| 3545 | IDP T1 FAST ROIs R thalamus | GCST90002548 | 4.08 |
| 3546 | CD93 levels | GCST90468656 | 4.08 |
| 3547 | IDP dMRI TBSS L2 Uncinate fasciculus L | GCST90004168 | 4.08 |
| 3548 | Principal component-derived dietary pattern 58 | GCST90133061 | 4.07 |
| 3549 | Corneal hysteresis (left) | Intraocular pressure | UKBB00000148 | 4.07 |
| 3550 | Phosphatidylcholine levels | GCST90499240 | 4.07 |
| 3551 | FYN levels | GCST90243200 | 4.07 |
| 3552 | T1 FreeSurfer DK lh precuneus volume | GCST90385680 | 4.06 |
| 3553 | rfMRI amplitudes (ICA100 node 11) | GCST90004599 | 4.05 |
| 3554 | Sphingomyelin_34:1_[M+H]1+ levels | GCST90060239 | 4.05 |
| 3555 | ThalamNuclei rh volume VAmc | GCST90002747 | 4.05 |
| 3556 | Electrocardiogram morphology (amplitude at temporal datapoints) unadjusted, T457 | ECGU000457 | 4.05 |
| 3557 | Triglyceride levels in large VLDL | GCST90092878 | 4.05 |
| 3558 | DTI TBSS FA Posterior corona radiata R | GCST90384406 | 4.04 |
| 3559 | Corneal resistance factor (left) | Intraocular pressure | UKBB00000150 | 4.04 |
| 3560 | Electrocardiogram morphology (amplitude at temporal datapoints) adjusted, T275 | ECGA000275 | 4.03 |
| 3561 | Sphingomyelin (d18:2/23:0, d18:1/23:1, d17:1/24:1) levels | GCST90200033 | 4.03 |
| 3562 | total cholesterol (maximum, inv-norm transformed) | GCST90476420 | 4.03 |
| 3563 | IDP dMRI TBSS ICVF Medial lemniscus R | GCST90004335 | 4.03 |
| 3564 | Atherosclerosis (PheCode 440) | GCST90475989 | 4.03 |
| 3565 | Electrocardiogram morphology (amplitude at temporal datapoints) unadjusted, T252 | ECGU000252 | 4.02 |
| 3566 | Electrocardiogram morphology (amplitude at temporal datapoints) adjusted, T345 | ECGA000345 | 4.02 |
| 3567 | ADGRE5/NOTCH1 ratio | GCST90313181 | 4.02 |
| 3568 | Lesion of plantar nerve | FING00000720 | 4.02 |
| 3569 | Malignant neoplasm of liver, primary (PheCode 155.1) | GCST90475569 | 4.02 |
| 3570 | Fasting insulin | GCST90002238 | 4.01 |
| 3571 | AGRP/NPY ratio | GCST90313203 | 4.01 |
| 3572 | Loneliness, isolation | Mental health | UKBB00000408 | 4.01 |
| 3573 | T1 brain MRIs Unsupervised Deep learning derived Imaging Phenotypes (dimension 111) | GCST90320674 | 4.01 |
| 3574 | Obesity | GCST001475 | 4.01 |
| 3575 | IDP SWI T2star left pallidum | GCST90003869 | 4.01 |
| 3576 | Mean bone marrow fat fraction of thoracic vertebrae 8-12 | GCST90652385 | 4.00 |
| 3577 | Electrocardiogram morphology (amplitude at temporal datapoints) unadjusted, T172 | ECGU000172 | 4.00 |
| 3578 | Phospholipids in small LDL | GCST90499673 | 4.00 |
| 3579 | EGFR/FAP ratio | GCST90314613 | 4.00 |
| 3580 | TREM2 levels | GCST90470960 | 4.00 |
| 3581 | Electrocardiogram morphology (amplitude at temporal datapoints) adjusted, T368 | ECGA000368 | 3.99 |
| 3582 | GLB1/IMPA1 ratio | GCST90314932 | 3.99 |
| 3583 | DTI autoptx L3 slf l tract | GCST90385214 | 3.99 |
| 3584 | Electrocardiogram morphology (amplitude at temporal datapoints) unadjusted, T247 | ECGU000247 | 3.99 |
| 3585 | DTI TBSS L2 Posterior thalamic radiation L | GCST90384505 | 3.99 |
| 3586 | Personal history of certain other diseases | Persons with potential health hazards related to family and personal history and certain conditions influencing health status | UKBB00000642 | 3.99 |
| 3587 | Epiandrosterone sulfate levels | GCST90199752 | 3.98 |
| 3588 | Phospholipid levels in chylomicrons and extremely large VLDL | GCST90501042 | 3.98 |
| 3589 | SLC9A3R2 levels | GCST90470666 | 3.97 |
| 3590 | FGF19/SCG2 ratio | GCST90314809 | 3.97 |
| 3591 | Electrocardiogram morphology (amplitude at temporal datapoints) adjusted, T194 | ECGA000194 | 3.97 |
| 3592 | Saturated fatty acids levels | GCST90499953 | 3.97 |
| 3593 | SPTLC1 levels | GCST90427130 | 3.97 |
| 3594 | SERPINB9 levels | GCST90470593 | 3.96 |
| 3595 | CAG-776 abundance in stool | GCST90032297 | 3.96 |
| 3596 | 1-(1-enyl-palmitoyl)-2-palmitoleoyl-GPC (P-16:0/16:1) levels | GCST90200070 | 3.96 |
| 3597 | DTI TBSS L2 Tapetum L | GCST90384523 | 3.96 |
| 3598 | T2 brain MRIs Unsupervised Deep learning derived Imaging Phenotypes (dimension 105) | GCST90320924 | 3.96 |
| 3599 | PCSK9 levels | GCST90428110 | 3.96 |
| 3600 | Prospective memory result | Prospective memory | UKBB00000713 | 3.95 |
| 3601 | Non-cancer illness code, self-reported - high cholesterol | Medical conditions | UKBB00000516 | 3.95 |
| 3602 | Electrocardiogram morphology (amplitude at temporal datapoints) unadjusted, T222 | ECGU000222 | 3.94 |
| 3603 | RBP7 levels | GCST90470440 | 3.94 |
| 3604 | DTI TBSS MO Corticospinal tract R | GCST90384626 | 3.94 |
| 3605 | X-21471 levels | GCST90200586 | 3.94 |
| 3606 | TFRC levels | GCST90470840 | 3.93 |
| 3607 | Electrocardiogram morphology (amplitude at temporal datapoints) adjusted, T314 | ECGA000314 | 3.93 |
| 3608 | CREG1 levels | GCST90468857 | 3.92 |
| 3609 | Saturated fatty acids levels | GCST90502192 | 3.92 |
| 3610 | MEGF10 levels | GCST90469882 | 3.92 |
| 3611 | ITPR1 levels | GCST90469655 | 3.92 |
| 3612 | PPP1R2/TBL1X ratio | GCST90315720 | 3.91 |
| 3613 | Omega-3 fatty acid levels | GCST90502423 | 3.91 |
| 3614 | DTI TBSS FA Retrolenticular part of internal capsule R | GCST90384400 | 3.91 |
| 3615 | Other diseases of intestines | FING00001001 | 3.91 |
| 3616 | Electrocardiogram morphology (amplitude at temporal datapoints) unadjusted, T20 | ECGU000020 | 3.91 |
| 3617 | LEP levels | GCST90469757 | 3.90 |
| 3618 | Monounsaturated fatty acid levels | GCST90502029 | 3.89 |
| 3619 | DTI autoptx L1 ptr l tract | GCST90385158 | 3.89 |
| 3620 | Cervical disc disorders | FING00000265 | 3.88 |
| 3621 | Electrocardiogram morphology (amplitude at temporal datapoints) unadjusted, T248 | ECGU000248 | 3.87 |
| 3622 | CPB2 levels | GCST90468840 | 3.87 |
| 3623 | Electrocardiogram morphology (amplitude at temporal datapoints) adjusted, T335 | ECGA000335 | 3.87 |
| 3624 | Operation code - bunion/hallus valgus surgery | Operations | UKBB00000551 | 3.87 |
| 3625 | Gut bacterial pathway abundance (PYRIDNUCSYN.PWY..NAD.biosynthesis.I..from.aspartate.) | GCST90027638 | 3.87 |
| 3626 | AXL/CD163 ratio | GCST90313418 | 3.87 |
| 3627 | IDP dMRI TBSS L1 Cingulum hippocampus L | GCST90004112 | 3.86 |
| 3628 | aparc-Desikan rh thickness paracentral | GCST90003495 | 3.86 |
| 3629 | Cancer of prostate (PheCode 185) | GCST90475591 | 3.86 |
| 3630 | MMP8/PGLYRP1 ratio | GCST90315465 | 3.86 |
| 3631 | IDP dMRI ProbtrackX L3 ar l | GCST90004300 | 3.85 |
| 3632 | ADAM15 levels | GCST90468217 | 3.85 |
| 3633 | Cholesterol to total lipids ratio in chylomicrons and extremely large VLDL | GCST90093041 | 3.85 |
| 3634 | T1 FreeSurfer a2009s rh G cuneus area | GCST90384900 | 3.85 |
| 3635 | Monounsaturated fatty acids to total fatty acids percentage | GCST90502385 | 3.84 |
| 3636 | High cholesterol | GCST90468134 | 3.84 |
| 3637 | CD69/TXNDC5 ratio | GCST90313889 | 3.84 |
| 3638 | Multiple myeloma | GCST90624747 | 3.84 |
| 3639 | UFC1 levels | GCST90243245 | 3.84 |
| 3640 | Osteochondrodysplasia with defects of growth of tubular bones and spine | FING00000910 | 3.84 |
| 3641 | wg rh intensity-contrast lingual | GCST90003839 | 3.84 |
| 3642 | IDP T1 FAST ROIs L cerebellum VIIIa | GCST90002578 | 3.84 |
| 3643 | Triglycerides to total lipids in small HDL percentage (UKB data field 23648) | GCST90269745 | 3.84 |
| 3644 | Bone marrow fat fraction of lumbar vertebra 3 | GCST90652388 | 3.84 |
| 3645 | Burger liking | GCST90094715 | 3.83 |
| 3646 | BA-exvivo lh volume entorhinal | GCST90002848 | 3.83 |
| 3647 | Takes medication for Sleep apnea? | GCST90475258 | 3.83 |
| 3648 | Substance abuse (more control exclusions) | FING00001341 | 3.83 |
| 3649 | ERBB3 levels | GCST90469140 | 3.83 |
| 3650 | Triacylglycerol_54:4_[M+NH4]1+ levels | GCST90060540 | 3.83 |
| 3651 | Sleep apnea | GCST90475824 | 3.83 |
| 3652 | Fasting glucose | GCST90002232 | 3.82 |
| 3653 | Disorders of lipoprotein metabolism and other lipidaemias | FING00000442 | 3.82 |
| 3654 | IDP dMRI TBSS ICVF Retrolenticular part of internal capsule R | GCST90004347 | 3.82 |
| 3655 | Systolic blood pressure, combined automated + manual reading, adjusted by medication | Cardiovascular measurement | UKBB00000809 | 3.82 |
| 3656 | RRM2B/SMAD1 ratio | GCST90315788 | 3.82 |
| 3657 | Electrocardiogram morphology (amplitude at temporal datapoints) adjusted, T369 | ECGA000369 | 3.82 |
| 3658 | ITGB1BP2/SKAP2 ratio | GCST90315219 | 3.82 |
| 3659 | VGF levels | GCST90471038 | 3.81 |
| 3660 | ALPP/LAMP3 ratio | GCST90313249 | 3.81 |
| 3661 | Phosphatidylcholine-O_40:6_[M+H]1+/Phosphatidylcholine-P_40:5_[M+H]1+ levels | GCST90060420 | 3.81 |
| 3662 | Postinflammatory pulmonary fibrosis (PheCode 502) | GCST90476032 | 3.81 |
| 3663 | Electrocardiogram morphology (amplitude at temporal datapoints) adjusted, T417 | ECGA000417 | 3.81 |
| 3664 | Concentration of chylomicrons and extremely large VLDL particles | GCST90093047 | 3.80 |
| 3665 | CEACAM19 levels | GCST90468691 | 3.80 |
| 3666 | ICAM4 levels | GCST90469501 | 3.80 |
| 3667 | MMP7 levels | GCST90469921 | 3.80 |
| 3668 | FAP levels | GCST90469189 | 3.80 |
| 3669 | Electrocardiogram morphology (amplitude at temporal datapoints) adjusted, T258 | ECGA000258 | 3.79 |
| 3670 | IDP dMRI TBSS L2 Anterior limb of internal capsule L | GCST90004140 | 3.79 |
| 3671 | Electrocardiogram morphology (amplitude at temporal datapoints) unadjusted, T158 | ECGU000158 | 3.79 |
| 3672 | IDP T1 FAST ROIs L caudate | GCST90002549 | 3.78 |
| 3673 | T2 brain MRIs Unsupervised Deep learning derived Imaging Phenotypes (dimension 109) | GCST90320928 | 3.78 |
| 3674 | T2 brain MRIs Unsupervised Deep learning derived Imaging Phenotypes (dimension 121) | GCST90320940 | 3.78 |
| 3675 | IDP dMRI ProbtrackX MD cgh l | GCST90004225 | 3.78 |
| 3676 | BA-exvivo rh thickness BA4a | GCST90003531 | 3.78 |
| 3677 | Acetoacetate levels | GCST90092804 | 3.78 |
| 3678 | Triglycerides in large VLDL (UKB data field 23501) | GCST90269598 | 3.77 |
| 3679 | Electrocardiogram morphology (amplitude at temporal datapoints) unadjusted, T110 | ECGU000110 | 3.77 |
| 3680 | HippSubfield lh volume Hippocampal-tail | GCST90002668 | 3.77 |
| 3681 | MMP13 levels | GCST90469917 | 3.76 |
| 3682 | AXL/VCAM1 ratio | GCST90313423 | 3.76 |
| 3683 | CPA2/ITGB7 ratio | GCST90314207 | 3.76 |
| 3684 | 5alpha-androstan-3beta,17beta-diol monosulfate (2) levels | GCST90199855 | 3.75 |
| 3685 | aparc-a2009s rh volume G-occipital-sup | GCST90003018 | 3.75 |
| 3686 | IDP dMRI TBSS L1 Cingulum cingulate gyrus R | GCST90004109 | 3.75 |
| 3687 | CEACAM16 levels | GCST90468689 | 3.75 |
| 3688 | X-24406 metabolite level | GCST90616789 | 3.75 |
| 3689 | Free testosterone levels | GCST90239825 | 3.75 |
| 3690 | Electrocardiogram morphology (amplitude at temporal datapoints) unadjusted, T15 | ECGU000015 | 3.74 |
| 3691 | aparc-DKTatlas lh area entorhinal | GCST90003238 | 3.74 |
| 3692 | Electrocardiogram morphology (amplitude at temporal datapoints) unadjusted, T251 | ECGU000251 | 3.74 |
| 3693 | ASAH2 levels | GCST90468374 | 3.74 |
| 3694 | Electrocardiogram morphology (amplitude at temporal datapoints) unadjusted, T485 | ECGU000485 | 3.74 |
| 3695 | Systolic blood pressure, combined automated + manual reading, adjusted by medication | Cardiovascular measurement | UKBB00000808 | 3.74 |
| 3696 | Synovitis and tenosynovitis (PheCode 727.1) | GCST90476242 | 3.74 |
| 3697 | Cholesteryl Esters in Small LDL | GCST90499586 | 3.74 |
| 3698 | Electrocardiogram morphology (amplitude at temporal datapoints) unadjusted, T241 | ECGU000241 | 3.73 |
| 3699 | Diastolic blood pressure | GCST90278625 | 3.73 |
| 3700 | Macular degeneration | GCST90475386 | 3.73 |
| 3701 | X-24328 levels | GCST90200624 | 3.73 |
| 3702 | Electrocardiogram morphology (amplitude at temporal datapoints) unadjusted, T109 | ECGU000109 | 3.73 |
| 3703 | Migraine | GCST90468142 | 3.72 |
| 3704 | HSPG2/SMOC2 ratio | GCST90315093 | 3.71 |
| 3705 | aseg rh volume Accumbens-area | GCST90002643 | 3.71 |
| 3706 | N6-methyllysine levels in chronic kidney disease | GCST90257530 | 3.71 |
| 3707 | Electrocardiogram morphology (amplitude at temporal datapoints) adjusted, T235 | ECGA000235 | 3.70 |
| 3708 | Other disorders of urethra and urinary system | FING00001039 | 3.70 |
| 3709 | PPP1R12A/TXNDC5 ratio | GCST90315714 | 3.69 |
| 3710 | Phosphatidylcholine_35:2_[M+H]1+/Phosphatidylethanolamine_38:2_[M+H]1+/Phosphatidate_40:3_[M+NH4]1+ levels | GCST90060325 | 3.69 |
| 3711 | CD163/FOLR2 ratio | GCST90313734 | 3.69 |
| 3712 | ICA1/MVK ratio | GCST90315108 | 3.69 |
| 3713 | TRAF3 levels | GCST90470957 | 3.68 |
| 3714 | ASPN levels | GCST90468377 | 3.68 |
| 3715 | AGXT/MME ratio | GCST90313207 | 3.68 |
| 3716 | Electrocardiogram morphology (amplitude at temporal datapoints) adjusted, T326 | ECGA000326 | 3.67 |
| 3717 | Triglycerides in very large VLDL (UKB data field 23494) | GCST90269591 | 3.67 |
| 3718 | Triacylglycerol_46:5_[M+NH4]1+ levels | GCST90060356 | 3.67 |
| 3719 | Free cholesterol levels in large LDL | GCST003665 | 3.67 |
| 3720 | Electrocardiogram morphology (amplitude at temporal datapoints) adjusted, T339 | ECGA000339 | 3.67 |
| 3721 | Electrocardiogram morphology (amplitude at temporal datapoints) unadjusted, T192 | ECGU000192 | 3.67 |
| 3722 | Electrocardiogram morphology (amplitude at temporal datapoints) adjusted, T460 | ECGA000460 | 3.66 |
| 3723 | Docosahexaenoic acid to total fatty acids percentage | GCST90502281 | 3.65 |
| 3724 | Monounsaturated fatty acid levels | GCST90502358 | 3.65 |
| 3725 | HRC levels | GCST90469475 | 3.65 |
| 3726 | DTI TBSS MD Anterior limb of internal capsule R | GCST90384588 | 3.64 |
| 3727 | Total lipids in small VLDL | GCST90499849 | 3.64 |
| 3728 | Systolic blood pressure | GCST90301696 | 3.64 |
| 3729 | Alcohol usually taken with meals | Alcohol | UKBB00000025 | 3.64 |
| 3730 | Total lipid levels in chylomicrons and extremely large VLDL | GCST90501002 | 3.64 |
| 3731 | Illnesses of mother - High blood pressure | Family history | UKBB00000348 | 3.64 |
| 3732 | Operation code - anterior/posterior repair bladder/uterus | Operations | UKBB00000548 | 3.64 |
| 3733 | Illnesses of father - High blood pressure | Family history | UKBB00000343 | 3.64 |
| 3734 | Cataracts | GCST90475382 | 3.64 |
| 3735 | T1 FreeSurfer BA rh BA3a exvivo thickness | GCST90385563 | 3.64 |
| 3736 | Electrocardiogram morphology (amplitude at temporal datapoints) unadjusted, T249 | ECGU000249 | 3.64 |
| 3737 | Volume of left whole amygdala | GCST90474898 | 3.63 |
| 3738 | Cerebrospinal fluid beta-hydroxyisovaleroylcarnitine levels | GCST90318013 | 3.63 |
| 3739 | Electrocardiogram morphology (amplitude at temporal datapoints) unadjusted, T463 | ECGU000463 | 3.63 |
| 3740 | IDP dMRI ProbtrackX L3 slf r | GCST90004322 | 3.62 |
| 3741 | Phospholipids in very large VLDL (UKB data field 23490) | GCST90269587 | 3.62 |
| 3742 | Excessive, frequent and irregular menstruation | FING00000524 | 3.62 |
| 3743 | Electrocardiogram morphology (amplitude at temporal datapoints) unadjusted, T269 | ECGU000269 | 3.62 |
| 3744 | IPCEF1/TBCB ratio | GCST90315187 | 3.62 |
| 3745 | Right-hemisphere salience/ventral attention network to right-hemisphere default mode network white-matter structural connectivity | GCST90302816 | 3.62 |
| 3746 | BTN2A1/LILRB4 ratio | GCST90313546 | 3.61 |
| 3747 | Parental longevity (father's age at death) | GCST006700 | 3.61 |
| 3748 | Electrocardiogram morphology (amplitude at temporal datapoints) unadjusted, T179 | ECGU000179 | 3.61 |
| 3749 | Angina pectoris | FING00000086 | 3.61 |
| 3750 | IDP dMRI TBSS MO Superior corona radiata R | GCST90003976 | 3.61 |
| 3751 | Heart rate variability (corrected standard deviation of normal-to-normal intervals) | GCST90281266 | 3.61 |
| 3752 | Electrocardiogram morphology (amplitude at temporal datapoints) unadjusted, T246 | ECGU000246 | 3.61 |
| 3753 | Medication use (antihypertensives) | GCST90018764 | 3.60 |
| 3754 | Red blood cell count | GCST90278641 | 3.60 |
| 3755 | VSNL1 levels | GCST90471054 | 3.60 |
| 3756 | FGL1 levels | GCST90469235 | 3.59 |
| 3757 | Lactate levels (UKB data field 23471) | GCST90269568 | 3.59 |
| 3758 | EREG/MPIG6B ratio | GCST90314704 | 3.59 |
| 3759 | CCN5 levels | GCST90468591 | 3.59 |
| 3760 | Feeling lonely | GCST006942 | 3.59 |
| 3761 | Electrocardiogram morphology (amplitude at temporal datapoints) unadjusted, T218 | ECGU000218 | 3.59 |
| 3762 | Electrocardiogram morphology (amplitude at temporal datapoints) adjusted, T184 | ECGA000184 | 3.59 |
| 3763 | Age completed full time education | Education | UKBB00000013 | 3.59 |
| 3764 | Electrocardiogram morphology (amplitude at temporal datapoints) unadjusted, T27 | ECGU000027 | 3.59 |
| 3765 | CD4/LILRB4 ratio | GCST90313843 | 3.59 |
| 3766 | ITGB1BP2/MITD1 ratio | GCST90315214 | 3.59 |
| 3767 | KCNA10 levels | GCST90617893 | 3.59 |
| 3768 | Concentration of large VLDL particles (UKB data field 23495) | GCST90269592 | 3.58 |
| 3769 | CNPY4/ERBIN ratio | GCST90314148 | 3.58 |
| 3770 | low density lipoprotein cholesterol (LDLC, mean, inv-norm transformed) | GCST90475416 | 3.58 |
| 3771 | Free Cholesterol in VLDL | GCST90500217 | 3.58 |
| 3772 | VSIG10 levels | GCST90471050 | 3.58 |
| 3773 | Atrial fibrillation and flutter (PheCode 427.2) | GCST90475967 | 3.57 |
| 3774 | Lung cancer | GCST90018655 | 3.57 |
| 3775 | aparc-DKTatlas rh area inferiorparietal | GCST90003271 | 3.56 |
| 3776 | T2 brain MRIs Unsupervised Deep learning derived Imaging Phenotypes (dimension 90) | GCST90320909 | 3.56 |
| 3777 | Electrocardiogram morphology (amplitude at temporal datapoints) adjusted, T231 | ECGA000231 | 3.56 |
| 3778 | Placental weight (paternal genotype, adjusted for sex and gestational age) | GCST90275191 | 3.56 |
| 3779 | Any dementia (more control exclusions) | FING00000099 | 3.56 |
| 3780 | ERN1 levels | GCST90469148 | 3.56 |
| 3781 | Nonalcoholic fatty liver disease in overweight individuals (25<=BMI<=30) | GCST90275047 | 3.56 |
| 3782 | Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage | GCST90501092 | 3.56 |
| 3783 | NOS1 levels | GCST90470062 | 3.56 |
| 3784 | DTI TBSS FA Splenium of corpus callosum | GCST90384384 | 3.56 |
| 3785 | T2 brain MRIs Unsupervised Deep learning derived Imaging Phenotypes (dimension 37) | GCST90320856 | 3.55 |
| 3786 | BA-exvivo rh thickness BA3b | GCST90003530 | 3.55 |
| 3787 | Metabolic disorder, other/unspecified | FING00000815 | 3.55 |
| 3788 | F-dairy liking (derived food-liking factor) | GCST90094751 | 3.55 |
| 3789 | Mean arterial pressure, automated reading, adjusted by medication | Cardiovascular measurement | UKBB00000436 | 3.55 |
| 3790 | T1 brain MRIs Unsupervised Deep learning derived Imaging Phenotypes (dimension 108) | GCST90320671 | 3.55 |
| 3791 | CD63/CLEC1B ratio | GCST90313863 | 3.54 |
| 3792 | T2 brain MRIs Unsupervised Deep learning derived Imaging Phenotypes (dimension 94) | GCST90320913 | 3.54 |
| 3793 | Saturated fatty acids to total fatty acids percentage | GCST90502700 | 3.54 |
| 3794 | Electrocardiogram morphology (amplitude at temporal datapoints) adjusted, T332 | ECGA000332 | 3.54 |
| 3795 | IDP T1 FAST ROIs R temporal pole | GCST90002466 | 3.53 |
| 3796 | T2 brain MRIs Unsupervised Deep learning derived Imaging Phenotypes (dimension 81) | GCST90320900 | 3.53 |
| 3797 | IL22RA2 levels | GCST90090699 | 3.53 |
| 3798 | IDP T1 FAST ROIs R cerebellum IX | GCST90002586 | 3.53 |
| 3799 | IDP dMRI TBSS L2 Uncinate fasciculus R | GCST90004167 | 3.53 |
| 3800 | PLA2G1B/PRSS2 ratio | GCST90315665 | 3.53 |
| 3801 | Electrocardiogram morphology (amplitude at temporal datapoints) adjusted, T260 | ECGA000260 | 3.53 |
| 3802 | OXT levels | GCST90470139 | 3.53 |
| 3803 | Medication use (agents acting on the renin-angiotensin system) | GCST90018768 | 3.52 |
| 3804 | Hyperlipidemia | GCST90090994 | 3.52 |
| 3805 | Electrocardiogram morphology (amplitude at temporal datapoints) unadjusted, T400 | ECGU000400 | 3.52 |
| 3806 | IDP dMRI TBSS MD Body of corpus callosum | GCST90004030 | 3.52 |
| 3807 | Illnesses of mother - Diabetes | Family history | UKBB00000347 | 3.51 |
| 3808 | Microvirga abundance in stool | GCST90032479 | 3.51 |
| 3809 | CTSC levels | GCST90468909 | 3.51 |
| 3810 | total cholesterol (mean, inv-norm transformed) | GCST90476424 | 3.51 |
| 3811 | Hearing difficulty with background noise | GCST90245775 | 3.51 |
| 3812 | Saturated fatty acids levels | GCST90502675 | 3.50 |
| 3813 | Peripheral vascular disease | GCST90086134 | 3.50 |
| 3814 | Cholesteryl esters in chylomicrons and extremely large VLDL (UKB data field 23485) | GCST90269582 | 3.50 |
| 3815 | Retinal detachments and defects (PheCode 361) | GCST90475845 | 3.50 |
| 3816 | IDP dMRI ProbtrackX ICVF atr l | GCST90004377 | 3.50 |
| 3817 | Lung adenocarcinoma | GCST004744 | 3.50 |
| 3818 | Atrial fibrillation (PheCode 427.21) | GCST90475970 | 3.49 |
| 3819 | Hearing aid user (UKB data field 3393) | GCST90043741 | 3.49 |
| 3820 | DTI TBSS L1 Posterior thalamic radiation L | GCST90384457 | 3.49 |
| 3821 | Body mass index | GCST90278622 | 3.49 |
| 3822 | Free cholesterol to total lipids in very small VLDL percentage (UKB data field 23607) | GCST90269704 | 3.48 |
| 3823 | Uterine fibroids | GCST90018714 | 3.47 |
| 3824 | High cholesterol | GCST90475205 | 3.47 |
| 3825 | BBQ/grilled meat liking | GCST90094698 | 3.47 |
| 3826 | CTSH levels | GCST90088501 | 3.47 |
| 3827 | Electrocardiogram morphology (amplitude at temporal datapoints) adjusted, T257 | ECGA000257 | 3.47 |
| 3828 | Linoleic acid to total fatty acids percentage | GCST90502333 | 3.47 |
| 3829 | FLT3LG levels | GCST90274791 | 3.47 |
| 3830 | WASF1 levels | GCST90471067 | 3.46 |
| 3831 | Total lipid levels in chylomicrons and extremely large VLDL | GCST90500994 | 3.46 |
| 3832 | CPQ levels | GCST90468846 | 3.46 |
| 3833 | Total lipids in small HDL | GCST90499443 | 3.45 |
| 3834 | Phosphatidate_34:2_[M-H]1- levels | GCST90060223 | 3.45 |
| 3835 | CES1 levels | GCST90468718 | 3.45 |
| 3836 | Low density lipoprotein cholesterol levels | GCST90278638 | 3.45 |
| 3837 | Cholesterol levels in chylomicrons and extremely large VLDL | GCST90093040 | 3.45 |
| 3838 | Electrocardiogram morphology (amplitude at temporal datapoints) adjusted, T344 | ECGA000344 | 3.45 |
| 3839 | PDCD1/TNFRSF4 ratio | GCST90315609 | 3.45 |
| 3840 | Electrocardiogram morphology (amplitude at temporal datapoints) unadjusted, T250 | ECGU000250 | 3.45 |
| 3841 | DTI autoptx L1 ilf r tract | GCST90385154 | 3.45 |
| 3842 | 1,2-dipalmitoyl-GPC (16:0/16:0) metabolite level | GCST90615438 | 3.44 |
| 3843 | STAB2 levels | GCST90470755 | 3.44 |
| 3844 | Never eat sugar vs no sugar restrictions (UKB data field 6144) | GCST90132934 | 3.44 |
| 3845 | Electrocardiogram morphology (amplitude at temporal datapoints) adjusted, T16 | ECGA000016 | 3.44 |
| 3846 | DTI TBSS FA Uncinate fasciculus L | GCST90384425 | 3.44 |
| 3847 | Body mass index | GCST90502912 | 3.44 |
| 3848 | NPY levels | GCST90470081 | 3.44 |
| 3849 | aseg rh volume Amygdala | GCST90002642 | 3.44 |
| 3850 | Triglycerides in LDL (UKB data field 23409) | GCST90269506 | 3.44 |
| 3851 | Average diameter for VLDL particles | GCST90500279 | 3.44 |
| 3852 | Electrocardiogram morphology (amplitude at temporal datapoints) adjusted, T386 | ECGA000386 | 3.44 |
| 3853 | Electrocardiogram morphology (amplitude at temporal datapoints) unadjusted, T239 | ECGU000239 | 3.43 |
| 3854 | Triglycerides to phosphoglycerides ratio (UKB data field 23435) | GCST90269532 | 3.43 |
| 3855 | Tea consumption | GCST90096926 | 3.43 |
| 3856 | Pain type(s) experienced in last month - Hip pain | Pain | UKBB00000628 | 3.42 |
| 3857 | Right ventricular stroke volume | GCST90268122 | 3.42 |
| 3858 | CSF1/LTBR ratio | GCST90314287 | 3.42 |
| 3859 | Electrocardiogram morphology (amplitude at temporal datapoints) unadjusted, T242 | ECGU000242 | 3.42 |
| 3860 | Electrocardiogram morphology (amplitude at temporal datapoints) unadjusted, T399 | ECGU000399 | 3.42 |
| 3861 | Honey liking | GCST90094782 | 3.41 |
| 3862 | BA-exvivo rh area BA3a | GCST90003223 | 3.41 |
| 3863 | Phospholipids in very small VLDL | GCST90500851 | 3.41 |
| 3864 | Use of dietary supplements (confirmatory factor analysis Factor 13) | GCST90309347 | 3.41 |
| 3865 | PLG levels | GCST90470257 | 3.41 |
| 3866 | Electrocardiogram morphology (amplitude at temporal datapoints) adjusted, T295 | ECGA000295 | 3.41 |
| 3867 | IDP dMRI TBSS L3 Cingulum hippocampus L | GCST90004208 | 3.41 |
| 3868 | aparc-a2009s lh volume S-circular-insula-sup | GCST90002973 | 3.40 |
| 3869 | Electrocardiogram morphology (amplitude at temporal datapoints) unadjusted, T375 | ECGU000375 | 3.40 |
| 3870 | Pulse pressure (BMI adjusted) | GCST90335167 | 3.40 |
| 3871 | Phosphatidylcholine_33:4_[M+H]1+/Phosphatidylethanolamine_36:4_[M+H]1+/Phosphatidate_38:5_[M+NH4]1+ levels | GCST90060273 | 3.40 |
| 3872 | IDP T1 FAST ROIs L parahipp gyrus post | GCST90002519 | 3.40 |
| 3873 | Concentration of small VLDL particles | GCST90499868 | 3.40 |
| 3874 | Electrocardiogram morphology (amplitude at temporal datapoints) adjusted, T343 | ECGA000343 | 3.40 |
| 3875 | Total cholesterol levels in LDL | GCST90132686 | 3.40 |
| 3876 | N-acetylalanine levels | GCST90200303 | 3.40 |
| 3877 | COL6A3/CST3 ratio | GCST90314174 | 3.39 |
| 3878 | Triglycerides to Total Lipids in Large LDL percentage | GCST90498092 | 3.39 |
| 3879 | Electrocardiogram morphology (amplitude at temporal datapoints) unadjusted, T271 | ECGU000271 | 3.38 |
| 3880 | Lung volume | GCST90016668 | 3.38 |
| 3881 | wg lh intensity-contrast rostralanteriorcingulate | GCST90003817 | 3.38 |
| 3882 | Sleep related movement disorders (PheCode 327.7) | GCST90475827 | 3.38 |
| 3883 | Uterine fibroids | GCST90461958 | 3.38 |
| 3884 | wg lh intensity-contrast paracentral | GCST90003808 | 3.38 |
| 3885 | High blood pressure / hypertension | GCST90475214 | 3.37 |
| 3886 | Immature fraction of reticulocytes | GCST90025971 | 3.37 |
| 3887 | Electrocardiogram morphology (amplitude at temporal datapoints) unadjusted, T471 | ECGU000471 | 3.37 |
| 3888 | Principal component-derived dietary pattern 30 | GCST90133035 | 3.37 |
| 3889 | DTI autoptx L3 atr r tract | GCST90385196 | 3.36 |
| 3890 | Triglyceride levels in very large VLDL | GCST90093026 | 3.36 |
| 3891 | Lifespan | GCST90551885 | 3.36 |
| 3892 | Diastolic blood pressure x sex interaction | GCST90335175 | 3.36 |
| 3893 | Concentration of medium LDL particles | GCST90498819 | 3.35 |
| 3894 | Phospholipid levels in chylomicrons and extremely large VLDL | GCST90093048 | 3.35 |
| 3895 | Qualifications - NVQ or HND or HNC or equivalent | Education | UKBB00000730 | 3.35 |
| 3896 | Drinks usually with meals in current drinkers (yes and it varies vs no) (UKB data field 1618) | GCST90132925 | 3.35 |
| 3897 | Mean arterial pressure, automated reading, adjusted by medication | Cardiovascular measurement | UKBB00000435 | 3.35 |
| 3898 | Total body bone mineral density (age 45-60) | GCST005350 | 3.34 |
| 3899 | Diastolic blood pressure (MTAG) | GCST90449057 | 3.34 |
| 3900 | Low hand grip strength (60 years and older) (FNIH) | GCST90007529 | 3.34 |
| 3901 | Hypertension | GCST90086091 | 3.34 |
| 3902 | HNRNPK levels | GCST90469469 | 3.34 |
| 3903 | Cholesterol to Total Lipids in Very Large VLDL percentage | GCST90500539 | 3.34 |
| 3904 | Intraocular pressure | GCST004074 | 3.34 |
| 3905 | Electrocardiogram morphology (amplitude at temporal datapoints) unadjusted, T171 | ECGU000171 | 3.34 |
| 3906 | TFF1 levels | GCST90470835 | 3.33 |
| 3907 | GFRAL levels | GCST90469331 | 3.33 |
| 3908 | Free cholesterol in very large VLDL (UKB data field 23493) | GCST90269590 | 3.32 |
| 3909 | LCN2/PRTN3 ratio | GCST90315307 | 3.32 |
| 3910 | Hip index | GCST90020026 | 3.32 |
| 3911 | Electrocardiogram morphology (amplitude at temporal datapoints) adjusted, T18 | ECGA000018 | 3.32 |
| 3912 | NECTIN2 levels | GCST90470020 | 3.32 |
| 3913 | IDP T1 SIENAX peripheral grey normalised volume | GCST90002426 | 3.32 |
| 3914 | IDP dMRI ProbtrackX FA ilf r | GCST90003940 | 3.32 |
| 3915 | BSG levels | GCST90468472 | 3.31 |
| 3916 | Cerebral ischemia (PheCode 433.3) | GCST90475988 | 3.31 |
| 3917 | Plays computer games | Electronic device use | UKBB00000649 | 3.31 |
| 3918 | Takes medication for high blood pressure? | GCST90475216 | 3.31 |
| 3919 | IDP T1 FAST ROIs L cerebellum VIIIb | GCST90002581 | 3.31 |
| 3920 | Electrocardiogram morphology (amplitude at temporal datapoints) adjusted, T274 | ECGA000274 | 3.31 |
| 3921 | F-sweetened coffee drink liking (derived food-liking factor) | GCST90094853 | 3.31 |
| 3922 | Corneal resistance factor | GCST90100568 | 3.30 |
| 3923 | Triglycerides to Total Lipids in Large HDL percentage | GCST90497906 | 3.30 |
| 3924 | Bullous keratopathy | FING00000231 | 3.30 |
| 3925 | Hypertension | FING00000637 | 3.29 |
| 3926 | IDP dMRI ProbtrackX ISOVF ar r | GCST90004526 | 3.29 |
| 3927 | UCMA levels | GCST90243285 | 3.29 |
| 3928 | Feeling nervous | GCST006948 | 3.29 |
| 3929 | DTI autoptx L2 atr r tract | GCST90385169 | 3.29 |
| 3930 | Electrocardiogram morphology (amplitude at temporal datapoints) unadjusted, T410 | ECGU000410 | 3.29 |
| 3931 | MUC16 levels | GCST90469964 | 3.28 |
| 3932 | Total lipids in very large VLDL (UKB data field 23489) | GCST90269586 | 3.28 |
| 3933 | ENO2/PRSS27 ratio | GCST90314666 | 3.28 |
| 3934 | Anemia in chronic kidney disease (PheCode 285.21) | GCST90475792 | 3.28 |
| 3935 | Triglycerides to Total Lipids in Very Large HDL percentage | GCST90500508 | 3.28 |
| 3936 | Triglycerides in chylomicrons and extremely large VLDL (UKB data field 23487) | GCST90269584 | 3.28 |
| 3937 | Colonic or urogenital fistula | FING00000315 | 3.27 |
| 3938 | Electrocardiogram morphology (amplitude at temporal datapoints) unadjusted, T9 | ECGU000009 | 3.27 |
| 3939 | COL6A3/SMOC2 ratio | GCST90314178 | 3.27 |
| 3940 | ThalamNuclei lh volume VAmc | GCST90002723 | 3.27 |
| 3941 | MOG levels | GCST90469929 | 3.26 |
| 3942 | Electrocardiogram morphology (amplitude at temporal datapoints) unadjusted, T312 | ECGU000312 | 3.26 |
| 3943 | Vascular/heart problems diagnosed by doctor - Angina | Medical conditions | UKBB00000896 | 3.26 |
| 3944 | Intrahepatic cholestasis of pregnancy | GCST90454199 | 3.25 |
| 3945 | NRAC levels | GCST90617991 | 3.25 |
| 3946 | IDP dMRI TBSS ICVF Superior cerebellar peduncle R | GCST90004339 | 3.25 |
| 3947 | Never eat sugar vs no eggs, dairy, wheat or sugar restrictions (UKB data field 6144) | GCST90132933 | 3.25 |
| 3948 | B4GALT1/SMOC2 ratio | GCST90313433 | 3.24 |
| 3949 | Physical activity | GCST90093323 | 3.24 |
| 3950 | Polyunsaturated fatty acids to total fatty acids percentage | GCST90502644 | 3.24 |
| 3951 | EHBP1 levels | GCST90469088 | 3.24 |
| 3952 | Mosaic chromosomal alteration of the Y chromosome | GCST90165289 | 3.24 |
| 3953 | Electrocardiogram morphology (amplitude at temporal datapoints) adjusted, T328 | ECGA000328 | 3.23 |
| 3954 | Electrocardiogram morphology (amplitude at temporal datapoints) unadjusted, T285 | ECGU000285 | 3.23 |
| 3955 | Electrocardiogram morphology (amplitude at temporal datapoints) unadjusted, T18 | ECGU000018 | 3.23 |
| 3956 | MAP4K5/TBCB ratio | GCST90315384 | 3.23 |
| 3957 | aseg lh volume Caudate | GCST90002621 | 3.23 |
| 3958 | DHEAS levels | GCST90199673 | 3.23 |
| 3959 | Electrocardiogram morphology (amplitude at temporal datapoints) unadjusted, T253 | ECGU000253 | 3.23 |
| 3960 | Electrocardiogram morphology (amplitude at temporal datapoints) unadjusted, T12 | ECGU000012 | 3.22 |
| 3961 | IDP dMRI TBSS ICVF Superior longitudinal fasciculus L | GCST90004368 | 3.22 |
| 3962 | aseg lh volume Cerebellum-White-Matter | GCST90002618 | 3.22 |
| 3963 | IDP dMRI TBSS MD Retrolenticular part of internal capsule L | GCST90004048 | 3.22 |
| 3964 | PFKM levels | GCST90618802 | 3.22 |
| 3965 | wg rh intensity-contrast precuneus | GCST90003851 | 3.22 |
| 3966 | Corns and callosities (PheCode 700) | GCST90476196 | 3.21 |
| 3967 | Hereditary corneal dystrophies | FING00000611 | 3.21 |
| 3968 | Triglycerides to Total Lipids in Small LDL percentage | GCST90499740 | 3.21 |
| 3969 | Triglycerides in HDL (UKB data field 23410) | GCST90269507 | 3.20 |
| 3970 | CORO1A levels | GCST90468832 | 3.20 |
| 3971 | Left-hemisphere default mode network to right-hemisphere default mode network white-matter structural connectivity | GCST90302766 | 3.19 |
| 3972 | Acute pulmonary heart disease (PheCode 415.1) | GCST90475944 | 3.19 |
| 3973 | Birth year infant mortality rates | GCST90095047 | 3.19 |
| 3974 | Colorectal adenocarcinoma, excluding all cancers (controls excluding all cancers) | FING00000316 | 3.19 |
| 3975 | Triglycerides in small LDL (UKB data field 23550) | GCST90269647 | 3.19 |
| 3976 | CD163/MSR1 ratio | GCST90313738 | 3.19 |
| 3977 | Treatment speciality of consultant (recoded) - Cardiology | Summary Administration | UKBB00000829 | 3.19 |
| 3978 | Pure hyperglyceridaemia | FING00001231 | 3.19 |
| 3979 | Chronic osteomyelitis (PheCode 710.12) | GCST90476223 | 3.18 |
| 3980 | ITGB1BP2/MED18 ratio | GCST90315213 | 3.18 |
| 3981 | X-11550 levels | GCST90243648 | 3.18 |
| 3982 | Principal component-derived dietary pattern 19 | GCST90133024 | 3.18 |
| 3983 | Volume of right central nucleus | GCST90474916 | 3.18 |
| 3984 | Electrocardiogram morphology (amplitude at temporal datapoints) adjusted, T456 | ECGA000456 | 3.18 |
| 3985 | Electrocardiogram morphology (amplitude at temporal datapoints) adjusted, T416 | ECGA000416 | 3.18 |
| 3986 | Omega-6 fatty acid levels | GCST90502515 | 3.17 |
| 3987 | Other disorders of ear | FING00001023 | 3.17 |
| 3988 | Biological Mother: Coronary Artery / Coronary Heart Disease | GCST90475488 | 3.17 |
| 3989 | Keratitis | FING00000708 | 3.17 |
| 3990 | Monounsaturated fatty acid levels | GCST90499094 | 3.16 |
| 3991 | DTI autoptx FA slf l tract | GCST90385133 | 3.16 |
| 3992 | Other and unspecified disorders of vitreous body | FING00000934 | 3.16 |
| 3993 | Type 2 diabetes, definitions combined | FING00001382 | 3.16 |
| 3994 | Electrocardiogram morphology (amplitude at temporal datapoints) unadjusted, T300 | ECGU000300 | 3.16 |
| 3995 | Ratio of docosahexaenoic acid to total fatty acid levels | GCST90092817 | 3.16 |
| 3996 | Mean arterial pressure, manual reading | Cardiovascular measurement | UKBB00000441 | 3.16 |
| 3997 | Tachycardia NOS (PheCode 427.7) | GCST90475979 | 3.16 |
| 3998 | Ceramide (d18:2/22:0) levels | GCST90024682 | 3.16 |
| 3999 | Peripheral enthesopathies and allied syndromes | musculoskeletal | UKBB00000640 | 3.16 |
| 4000 | Concentration of very large VLDL particles (UKB data field 23488) | GCST90269585 | 3.16 |